The Market Reports

Synopsis
The global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hemoperfusion cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
The hemoperfusion market is experiencing growing interest as healthcare providers increasingly adopt advanced blood purification techniques to manage various critical conditions, including drug overdoses, sepsis, and autoimmune diseases. Hemoperfusion, which involves passing blood through an adsorbent-containing cartridge to remove toxins, offers targeted and efficient detoxification that traditional dialysis cannot always achieve. This capability makes it particularly valuable in emergency care and intensive care settings, driving its adoption in hospitals and specialized clinics worldwide.
Additionally, technological advancements in cartridge materials and the integration of hemoperfusion with other extracorporeal therapies are enhancing the efficacy and safety of treatments. As awareness of its clinical benefits spreads and regulatory support strengthens, more healthcare systems in both developed and emerging markets are incorporating hemoperfusion into standard care protocols. However, market growth may still face challenges such as limited practitioner familiarity and cost considerations, which need to be addressed through education and innovation.
This report aims to provide a comprehensive presentation of the global market for Hemoperfusion, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hemoperfusion by region & country, by Type, and by Application.
The Hemoperfusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion.
Market Segmentation
By Company
Jianfan Biotech
Kangbei Medical
Foshan Boxin (Lily Medical)
Baxter
Asahi Kasei
Segment by Type
Activated Carbon Adsorption
Resin Adsorption
Segment by Application
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hemoperfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hemoperfusion in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index